Swiss Medica is a globally recognized leader in regenerative medicine, specializing in advanced stem cell therapies since 2011.

With over 10,000 patients treated worldwide, they provide personalized, science-based care for chronic and hard-to-treat conditions.

Headquartered in Switzerland, Swiss Medica operates state-of-the-art clinics in Serbia and Slovenia, fully equipped for the safe and effective application of mesenchymal stromal cells (MSCs). 

Additionally, their facility in Serbia houses a dedicated research center and an in-house stem cell production laboratory.